This federal contract award is for the delivery of NEUPOGEN 300 MCG/ML vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The contract has a ceiling value of $1,242.31 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 7/29/24, 9:25 AM